EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 160 filers reported holding EPIZYME INC in Q2 2020. The put-call ratio across all filers is 0.16 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $26,000 | +23.8% | 17,750 | -3.8% | 0.00% | – |
Q1 2022 | $21,000 | -54.3% | 18,450 | 0.0% | 0.00% | – |
Q4 2021 | $46,000 | -73.1% | 18,450 | -44.9% | 0.00% | – |
Q3 2021 | $171,000 | -34.7% | 33,478 | +6.4% | 0.00% | – |
Q2 2021 | $262,000 | -4.0% | 31,478 | +0.5% | 0.00% | – |
Q1 2021 | $273,000 | +11.9% | 31,328 | +39.3% | 0.00% | – |
Q4 2020 | $244,000 | +4.3% | 22,496 | +14.8% | 0.00% | – |
Q3 2020 | $234,000 | -17.0% | 19,596 | +11.5% | 0.00% | – |
Q2 2020 | $282,000 | +13.3% | 17,578 | +9.3% | 0.00% | -100.0% |
Q1 2020 | $249,000 | – | 16,082 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |